MedTrace Logo

Vagal Nerve Stimulation for Interoception Modulation

NCT03603730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-07-06

No results posted yet for this study

Summary

Explore the effects of variable ingested volumes and auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in healthy adults.

Conditions

  • Healthy Adult

Interventions

DEVICE

taVNS

Active taVNS delivered to the external ear at a moderate, non-painful level.

DEVICE

Sham taVNS

Sham taVNS delivered to the external ear using zero-current.

Sponsors & Collaborators

Principal Investigators

  • Roberta Sclocco, PhD · Spaulding Rehabilitation Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2025-09-24
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03603730 on ClinicalTrials.gov